Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes

What is the purpose of this trial?

The study examines the Safety and efficacy study of exenatide once weekly in children and adolescents with type 2 diabetes.


Participation Guidelines

Ages: 10 - 17 years

Gender: Both


Astra Zeneca, L.P.

Dates: 12/12/2016 - 01/31/2019

Last Updated: 12/13/2016

Study HIC#: 1603017474

Get Involved

For more information about this study, contact:
Amy Steffen
203-737-8852
amy.steffen@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

William V Tamborlane

Principal Investigator

Sub-Investigators